Aliases & Classifications for Myofascial Pain Syndrome

MalaCards integrated aliases for Myofascial Pain Syndrome:

Name: Myofascial Pain Syndrome 12 15
Myofascial Pain Syndromes 44 73
Myofascial Pain Dysfunction Syndrome 55
Fibromyalgia 73

Classifications:



External Ids:

Disease Ontology 12 DOID:431
MeSH 44 D009209

Summaries for Myofascial Pain Syndrome

MalaCards based summary : Myofascial Pain Syndrome, also known as myofascial pain syndromes, is related to fibromyalgia and paine syndrome, and has symptoms including back pain, fatigue and muscle cramp. An important gene associated with Myofascial Pain Syndrome is POMC (Proopiomelanocortin). The drugs Lidocaine and Menthol have been mentioned in the context of this disorder. Affiliated tissues include brain, testes and heart, and related phenotype is hematopoietic system.

Wikipedia : 76 Myofascial pain syndrome (MPS), also known as chronic myofascial pain (CMP), is a syndrome characterized... more...

Related Diseases for Myofascial Pain Syndrome

Diseases related to Myofascial Pain Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 34)
# Related Disease Score Top Affiliating Genes
1 fibromyalgia 11.8
2 paine syndrome 11.0
3 cervicitis 10.4
4 chronic fatigue syndrome 10.2
5 premenstrual tension 10.0 CAMP POMC
6 breast cancer 9.9
7 reflex sympathetic dystrophy 9.9
8 anxiety 9.9
9 algoneurodystrophy 9.9
10 chronic pain 9.9
11 mucolipidosis iii alpha/beta 9.9
12 temporal arteritis 9.8
13 trigeminal neuralgia 9.8
14 fibrosclerosis, multifocal 9.8
15 angioma, tufted 9.8
16 hemangioma 9.8
17 acute cervicitis 9.8
18 chronic cervicitis 9.8
19 bursitis 9.8
20 adenocarcinoma 9.8
21 laryngitis 9.8
22 intramuscular hemangioma 9.8
23 neuropathy 9.8
24 retroperitoneal fibrosis 9.8
25 depression 9.8
26 back pain 9.8
27 headache 9.8
28 epicondylitis 9.7 NDUFB8 TAC1
29 neurodermatitis 9.7 POMC TAC1
30 anismus 9.6 CAMP TAC1
31 pain agnosia 9.5 POMC TAC1
32 brachial plexus lesion 9.4 CAMP TAC1
33 agnosia 9.4 POMC TAC1
34 specific developmental disorder 9.2 POMC TAC1

Graphical network of the top 20 diseases related to Myofascial Pain Syndrome:



Diseases related to Myofascial Pain Syndrome

Symptoms & Phenotypes for Myofascial Pain Syndrome

UMLS symptoms related to Myofascial Pain Syndrome:


back pain, fatigue, muscle cramp, muscle rigidity, muscle spasticity, myoclonus, pain, sciatica, torticollis, chronic pain, muscle weakness, myalgia, myofascial trigger point pain

MGI Mouse Phenotypes related to Myofascial Pain Syndrome:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.02 CAMP NDUFB8 PDGFRB POMC PSTPIP1

Drugs & Therapeutics for Myofascial Pain Syndrome

Drugs for Myofascial Pain Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 350)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 137-58-6 3676
2
Menthol Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 2216-51-5 16666
3
Etoricoxib Approved, Investigational Phase 4 202409-33-4 123619
4
Dopamine Approved Phase 4,Phase 3,Phase 2,Not Applicable 51-61-6, 62-31-7 681
5
Acetylcholine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-84-3 187
6
Tramadol Approved, Investigational Phase 4,Phase 3,Phase 2 27203-92-5 33741
7
Norepinephrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-41-2 439260
8
Gabapentin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 60142-96-3 3446
9
Amitriptyline Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 50-48-6 2160
10
Pregabalin Approved, Illicit, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 148553-50-8 5486971
11
Naloxone Approved, Vet_approved Phase 4,Phase 2,Phase 1,Not Applicable 465-65-6 5284596
12
Acetaminophen Approved Phase 4,Phase 3,Phase 2,Not Applicable 103-90-2 1983
13
Milnacipran Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 92623-85-3 65833
14
Perphenazine Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 58-39-9 4748
15
Benzocaine Approved, Investigational Phase 4,Phase 1,Phase 2,Not Applicable 1994-09-7, 94-09-7 2337
16
Dinoprostone Approved Phase 4 363-24-6 5280360
17
Cyclobenzaprine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 303-53-7 2895
18
gamma-Aminobutyric acid Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 56-12-2 119
19
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 1 9004-61-9 53477741
20
Trazodone Approved, Investigational Phase 4 19794-93-5 5533
21
Iron Approved Phase 4,Phase 3,Phase 2 7439-89-6 23925
22
Modafinil Approved, Investigational Phase 4,Phase 3 68693-11-8 4236
23
Eszopiclone Approved, Investigational Phase 4 138729-47-2 969472
24
Colchicine Approved Phase 4 64-86-8 6167 2833
25
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2 75614-87-8, 51-45-6 774
26
Betamethasone Approved, Vet_approved Phase 4 378-44-9 9782
27
Paroxetine Approved, Investigational Phase 4,Phase 1,Phase 2 61869-08-7 43815
28
Fluoxetine Approved, Vet_approved Phase 4,Phase 3,Phase 2 54910-89-3 3386
29
Granisetron Approved, Investigational Phase 4 109889-09-0 3510
30
Naltrexone Approved, Investigational, Vet_approved Phase 4,Not Applicable 16590-41-3 5360515
31
Deferasirox Approved, Investigational Phase 4 201530-41-8 5493381
32
Armodafinil Approved, Investigational Phase 4,Phase 3 112111-43-0
33
Sodium oxybate Approved Phase 4,Phase 3,Phase 2 502-85-2 5360545
34
Flunarizine Approved Phase 4 52468-60-7 941361
35
Suvorexant Approved, Investigational Phase 4 1030377-33-3
36
Buprenorphine Approved, Illicit, Investigational, Vet_approved Phase 4 52485-79-7 40400 644073
37
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
38
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4 1406-16-2
39
Glutamic Acid Approved, Nutraceutical Phase 4,Not Applicable 56-86-0 33032
40 tannic acid Approved, Nutraceutical Phase 4,Phase 1,Phase 2,Not Applicable
41
Ergocalciferol Approved, Nutraceutical Phase 4 50-14-6 5280793
42
Vitamin D3 Approved, Nutraceutical Phase 4 67-97-0 6221 5280795
43 Analgesics Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
44 calcium channel blockers Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
45 abobotulinumtoxinA Phase 4,Phase 3,Phase 2,Phase 1
46 Central Nervous System Depressants Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
47 Adrenergic Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
48 Micronutrients Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
49 Cholinergic Agents Phase 4,Phase 3,Phase 2,Phase 1
50 GABA Agents Phase 4,Phase 3,Phase 2,Not Applicable

Interventional clinical trials:

(show top 50) (show all 818)
# Name Status NCT ID Phase Drugs
1 Study Assessing the Efficacy of Etoricoxib in Female Patients With Fibromyalgia Unknown status NCT00755521 Phase 4 etoricoxib
2 Study of Fibromyalgia Treated With Milnacipran Unknown status NCT01125423 Phase 4 Milnacipran
3 Cyclobenzaprine Extended Release (ER) for Fibromyalgia Unknown status NCT01041495 Phase 4 cyclobenzaprine ER (AMRIX);placebo
4 The Immune and Clinical Impacts of Vitamin D in Patients With Chronic Musculo-skeletal Pain Unknown status NCT01417923 Phase 4 vitamin D
5 Study to Evaluate the Efficacy of Milnacipran in the Treatment of Pain Due to Osteoarthritis Unknown status NCT01329406 Phase 4 Milnacipran;Placebo
6 The Impact of Perioperative Gabapentin on Chronic Groin Pain After Inguinal Hernia Repair Unknown status NCT02419443 Phase 4 Gabapentin;Placebo
7 Quetiapine Compared With Placebo in the Management of Fibromyalgia Completed NCT01458964 Phase 4 Quetiapine
8 Effect of Milnacipran on Pain in Fibromyalgia Completed NCT01288807 Phase 4 Milnacipram
9 Pool-based Exercise in Fibromyalgia Management Completed NCT00550641 Phase 4
10 Comparative Efficacy and Tolerability of Quetiapine XR and Amitriptyline in the Treatment of Fibromyalgia Completed NCT00766350 Phase 4 amitriptyline;quetiapine
11 Paroxetine-CR (Paxil-CR) in the Treatment of Patients With Fibromyalgia Syndrome Completed NCT00610610 Phase 4 Paroxetine CR;Placebo
12 Quetiapine (Seroquel XR) for the Treatment of Fibromyalgia: a Clinical and Mechanistic Pilot Study Completed NCT00983320 Phase 4 quetiapine;placebo
13 Strengthening Exercises for Fibromyalgia Completed NCT02063750 Phase 4
14 A Pilot Study on the Use of Nociceptive Flexion Reflex for Fibromyalgia Completed NCT00965601 Phase 4
15 Trazodone and Its Augmentation With Pregabalin in the Treatment of Fibromyalgia Completed NCT00791739 Phase 4 trazodone, pregabalin
16 Combining N-of-1 Trials to Assess Fibromyalgia Treatments Completed NCT00000428 Phase 4 Amitriptyline;Amitriptyline plus Fluoxitine
17 Discomfort and Psychosocial Difficulties in Fibromyalgia Completed NCT02078791 Phase 4 Botox infiltration
18 Discontinuation Study of the Durability of Effect of Milnacipran for the Treatment of Fibromyalgia Completed NCT01014585 Phase 4 Placebo;Milnacipran
19 Drug and Talk Therapy for Fibromyalgia Completed NCT01038323 Phase 4 Educational with milnacipran
20 Adolescent Fibromyalgia Study Completed NCT01020474 Phase 4 placebo;pregabalin (Lyrica)
21 Heart Rate Variability in Fibromyalgia - Effects of Strengthening Exercises Completed NCT02004405 Phase 4
22 Treatment of Myofascial Pain Syndrome With Lidocaine Injection and Physical Therapy. Completed NCT01250184 Phase 4 Lidocaine injection
23 Fixed Versus Flexible Dosing of Pregabalin in Patients With Fibromyalgia Completed NCT01226667 Phase 4 Pregabalin
24 Ai Chi Versus Stretching in Fibromyalgia Management Completed NCT00600574 Phase 4
25 A Study for Adult Patients With Fibromyalgia Completed NCT00965081 Phase 4 Duloxetine;Placebo
26 A Study to Evaluate the Effects of Milnacipran on Pain Processing and Functional MRI in Patients With Fibromyalgia Completed NCT01173055 Phase 4 milnacipran;Placebo
27 The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia Completed NCT01234675 Phase 4 Milnacipran;Milnacipran
28 Eszopiclone in the Treatment of Insomnia and Fibromyalgia Completed NCT00392041 Phase 4 Eszopiclone;placebo
29 Pregabalin In Adolescent Patients With Fibromyalgia Completed NCT01020526 Phase 4 pregabalin
30 An Efficacy Study of Combination of Tramadol and Acetaminophen Tablets in the Treatment of Participants With Fibromyalgia Pain Completed NCT00766675 Phase 4 Tramadol hydrochloride;Acetaminophen
31 Study of Milnacipran in Patients With Inadequate Response to Duloxetine for the Treatment of Fibromyalgia Completed NCT01077375 Phase 4 Placebo;Milnacipran
32 A Study Comparing Duloxetine and Placebo in the Treatment of Fibromyalgia Completed NCT00673452 Phase 4 duloxetine hydrochloride;placebo
33 EMINEM: Efficacy of Muscoril In NEck Myofascial Syndromes Completed NCT00272532 Phase 4 Thiocolchicoside
34 An Eight Week, Double-Blind Efficacy Study of Armodafinil Augmentation to Alleviate Fibromyalgia Fatigue Completed NCT00678691 Phase 4 armodafinil;placebo
35 A Study of Quetiapine Fumarate Sustained Release in Major Depression With Comorbid Fibromyalgia Syndrome Completed NCT00675896 Phase 4 Quetiapine Fumarate Sustained Release;Placebo
36 Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome Completed NCT00241215 Phase 4 Botulinum toxin serotype A
37 Patient Self-administration of Cortisol for Cortisol-responding Disorders in Men and Women Over the Age of 17 Completed NCT03558971 Phase 4 Cortisol
38 Milnacipran for Chronic Pain in Knee Osteoarthritis Completed NCT01510457 Phase 4 Milnacipran;Placebo
39 Comparison of the Efficacy of Duloxetine With Placebo in Patients With Chronic Low Back Pain With a Radicular Component Completed NCT01166048 Phase 4 Duloxetine;Duloxetine
40 Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome Completed NCT01071044 Phase 4 Lisdexamfetamine Dimesylate;Placebo "30, 50 or 70 mg"
41 Study on the Effect of Granisetron on Myofascial Pain in the Orofacial Muscles Completed NCT02230371 Phase 4 Granisetron;Control (placebo)
42 Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload Completed NCT00673608 Phase 4 deferasirox
43 A Double Blind Study Comparing Hyaluronic Acid, Corticosteroid and Placebo During Arthrocentesis for Temporomandibular Joint (TMJ) Dysfunction Completed NCT01524913 Phase 4 Hyaluronic acid;Corticosteroid;Lactated Ringers
44 Valuation of Efficacy and Safety of Vitamin D3 Use in 80 Women Diagnosed With Fibromyalgia. Using FIQ Score and VAS. Recruiting NCT03369379 Phase 4 D3 Vitamin
45 Low Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism? Recruiting NCT02806440 Phase 4 Low dose naltrexone;Placebo
46 Suvorexant in Insomnia Co-morbid With Fibromyalgia Recruiting NCT02684136 Phase 4 suvorexant;placebo
47 Neurologic Signatures of Chronic Pain Disorders Recruiting NCT02747940 Phase 4 flunarizine and/or pregabalin
48 Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty Enrolling by invitation NCT03271151 Phase 4 Cymbalta
49 Using Saline for Myofascial Pain Syndromes (USAMPS) Terminated NCT02120261 Phase 4
50 Influence of Transcranial Direct Current Stimulation of the Primary Motor Cortex on Pain Sensation in Patients Suffering From Fibromyalgia Syndrome Terminated NCT01261650 Phase 4

Search NIH Clinical Center for Myofascial Pain Syndrome

Cochrane evidence based reviews: myofascial pain syndromes

Genetic Tests for Myofascial Pain Syndrome

Anatomical Context for Myofascial Pain Syndrome

MalaCards organs/tissues related to Myofascial Pain Syndrome:

41
Brain, Testes, Heart, Cortex, Liver, Amygdala, Bone

Publications for Myofascial Pain Syndrome

Articles related to Myofascial Pain Syndrome:

(show top 50) (show all 250)
# Title Authors Year
1
Pathophysiology and Management of Abdominal Myofascial Pain Syndrome (AMPS): A Three-Year Prospective Audit of a Management Pathway in 120 Patients. ( 29444277 )
2018
2
The Distinction of Hot Herbal Compress, Hot Compress, and Topical Diclofenac as Myofascial Pain Syndrome Treatment. ( 29405762 )
2018
3
Concurrent validation of a pressure pain threshold scale for individuals with myofascial pain syndrome and fibromyalgia. ( 29456445 )
2018
4
Challenging the Cinderella Hypothesis: A New Model for the Role of the Motor Unit Recruitment Pattern in the Pathogenesis of Myofascial Pain Syndrome in Postural Muscles. ( 29944114 )
2018
5
The Effectiveness of Dry Needling and Exercise Therapy in Patients with Dizziness Caused By Cervical Myofascial Pain Syndrome; Prospective Randomized Clinical Study. ( 29718418 )
2018
6
Combination of exercise and acupuncture vs acupuncture alone for treatment of myofascial pain syndrome: A randomized clinical trial. ( 29746993 )
2018
7
Prevalence of myofascial pain syndrome in patients with incurable cancer. ( 29861227 )
2018
8
Methodological Issues on the Accuracy and Precision of Clinical Examination in the Diagnosis of Myofascial Pain Syndrome. ( 29788387 )
2018
9
Reply to "Clinical Examination in the Diagnosis of Myofascial Pain Syndrome; Methodological Issues on Validity and Reliability". ( 29788501 )
2018
10
Quantitative Ultrasound Using Texture Analysis of Myofascial Pain Syndrome in the Trapezius. ( 29717675 )
2018
11
Comparision of the effectiveness of ESWT and ultrasound treatments in myofascial pain syndrome: randomized, sham-controlled study. ( 29581669 )
2018
12
Comparision of two different dry-needling techniques in the treatment of myofascial pain syndrome. ( 28467572 )
2017
13
Reliability of assessment of upper trapezius morphology, its mechanical properties and blood flow in female patients with myofascial pain syndrome using ultrasonography. ( 28167187 )
2017
14
Acupuncture for Myofascial Pain Syndrome: A Network Meta-Analysis of 33 Randomized Controlled Trials. ( 28934793 )
2017
15
Far-infrared ray patches relieve pain and improve skin sensitivity in myofascial pain syndrome: A double-blind randomized controlled study. ( 29154057 )
2017
16
Extracorporeal Shock Wave Therapy Versus Trigger Point Injection in the Treatment of Myofascial Pain Syndrome in the Quadratus Lumborum. ( 28971042 )
2017
17
Assess pain intensity using photoplethysmography signal in chronic myofascial pain syndrome. ( 28502104 )
2017
18
Increased Risk of Myofascial Pain Syndrome Among Patients with Insomnia. ( 28339643 )
2017
19
A Multimodal Approach for Myofascial Pain Syndrome: A Prospective Study. ( 28739020 )
2017
20
Effect of dry needling on myofascial pain syndrome of the quadratus femoris: A case report. ( 28922048 )
2017
21
Comparison of the Efficiency of Ultrasound-Guided Injections of the Rhomboid Major and Trapezius Muscles in Myofascial Pain Syndrome: A Prospective Randomized Controlled Double-blind Study. ( 29048132 )
2017
22
Manual acupuncture for myofascial pain syndrome: a systematic review and meta-analysis. ( 28115321 )
2017
23
The effectiveness of Kinesio Taping on pain and disability in cervical myofascial pain syndrome. ( 28343625 )
2017
24
The Possible Role of Meditation in Myofascial Pain Syndrome: A New Hypothesis. ( 28503039 )
2017
25
Effectiveness of ultrasound therapy for myofascial pain syndrome: a systematic review and meta-analysis. ( 28331357 )
2017
26
Quantitative Ultrasound Assessment of Myofascial Pain Syndrome Affecting the Trapezius: A Reliability Study. ( 28670779 )
2017
27
Cutaneous silent period in myofascial pain syndrome. ( 28877555 )
2017
28
Characteristics of Myofascial Pain Syndrome of the Infraspinatus Muscle. ( 28971041 )
2017
29
Correction: Idiopathic Retroperitoneal Fibrosis With Myofascial Pain Syndrome: A Case Report. ( 29201835 )
2017
30
Corticospinal excitability as a biomarker of myofascial pain syndrome. ( 29392210 )
2017
31
Myofascial Pain Syndrome on Tc99m MDP Bone Scintigraphy. ( 28680220 )
2017
32
Comparison between ultrasound-guided interfascial pulsed radiofrequency and ultrasound-guided interfascial block with local anesthetic in myofascial pain syndrome of trapezius muscle. ( 28151904 )
2017
33
Pathophysiology of Trigger Points in Myofascial Pain Syndrome. ( 28379050 )
2017
34
Reliability of the Upper Trapezius Muscle and Fascia Thickness and Strain Ratio Measures by Ultrasonography and Sonoelastography in Participants With Myofascial Pain Syndrome. ( 29276464 )
2017
35
Validity and Reliability of Clinical Examination in the Diagnosis of Myofascial Pain Syndrome and Myofascial Trigger Points in Upper Quarter Muscles. ( 29253210 )
2017
36
The effectiveness of kinesio taping on pain and disabilty in cervical myofascial pain syndrome. ( 27036544 )
2016
37
Myofascial Pain Syndrome in the Elderly and Self-Exercise: A Single-Blind, Randomized, Controlled Trial. ( 26910293 )
2016
38
Evaluation of the Sympathetic Skin Response to the Dry Needling Treatment in Female Myofascial Pain Syndrome Patients. ( 27298659 )
2016
39
Prevalence of Myofascial Pain Syndrome in Chronic Non-Specific Neck Pain: A Population-Based Cross-Sectional Descriptive Study. ( 27330152 )
2016
40
Analgesic Effect of Botulinum Toxin A in Myofascial Pain Syndrome Patients Previously Treated with Local Infiltration of Anesthetic and Steroids. ( 27802066 )
2016
41
Ultrasonography in Diagnosis of Myofascial Pain Syndrome and Reliability of Novel Ultrasonic Indexes of Upper Trapezius Muscle. ( 28155823 )
2016
42
Comparative study of shock wave therapy and Laser therapy effect in elimination of symptoms among patients with myofascial pain syndrome in upper trapezius. ( 27656607 )
2016
43
Effects of Intramuscular Electrical Stimulation Using Inversely Placed Electrodes on Myofascial Pain Syndrome in the Shoulder: A Case Series. ( 27103970 )
2016
44
Impact of Needle Diameter on Long-Term Dry Needling Treatment of Chronic Lumbar Myofascial Pain Syndrome. ( 27333534 )
2016
45
Evolution of Muscles Dysfunction from Myofascial Pain Syndrome Through Cervical Disc-Root Conflict to Degenerative Spine Disease. ( 27196021 )
2016
46
Position Statement of the Israeli Society for Musculoskeletal Medicine on Intramuscular Stimulation for Myofascial Pain Syndrome-A Delphi Process. ( 27739181 )
2016
47
Effectiveness of dry needling on reducing pain intensity in patients with myofascial pain syndrome: a Meta-analysis. ( 26946612 )
2016
48
Treatment of myofascial pain syndrome with lidocaine injection and physical therapy, alone or in combination: a single blind, randomized, controlled clinical trial. ( 26911981 )
2016
49
Laryngeal myofascial pain syndrome as a new diagnostic entity of dysphonia. ( 27262220 )
2016
50
Referred symptom from myofascial pain syndrome: One of the most important causes of sensory disturbance in breast cancer patients using taxanes. ( 28004441 )
2016

Variations for Myofascial Pain Syndrome

Expression for Myofascial Pain Syndrome

Search GEO for disease gene expression data for Myofascial Pain Syndrome.

Pathways for Myofascial Pain Syndrome

GO Terms for Myofascial Pain Syndrome

Biological processes related to Myofascial Pain Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 neuropeptide signaling pathway GO:0007218 8.96 POMC TAC1
2 regulation of blood pressure GO:0008217 8.62 POMC TAC1

Molecular functions related to Myofascial Pain Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 signaling receptor binding GO:0005102 8.8 PDGFRB POMC TAC1

Sources for Myofascial Pain Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....